Suppr超能文献

口服铁吸收试验不应使用含三价铁的铁滴剂进行。

Oral iron absorption test should not be performed with iron drops containing ferric iron.

作者信息

Andersen Stine Linding, Gyrup Claus, Handberg Aase, Nielsen Gunnar Lauge

机构信息

Klinisk Biokemi, Aalborg Universitetshospital, Hobrovej 18-22, 9000 Aalborg, Denmark.

出版信息

Dan Med J. 2015 Aug;62(8):A5116.

Abstract

INTRODUCTION

In an oral iron absorption test (OIAT), the rise in plasma iron concentration after oral ingestion of iron is a measure of intestinal iron absorption. We describe results of the OIAT using two different formulations of oral iron drops.

METHODS

The study included all patients who had an OIAT performed at the Department of Internal Medicine, Farsø, Aalborg University Hospital, Denmark, from 1 January 2013 to 17 June 2014 (n = 24) using ferrous iron drops "Glycifer" and from 18 June to 3 November 2014 (n = 17) using ferric iron drops "Medic". A venous blood sample was drawn before and then 90, 180 and 240 min. after the intake of 9 ml iron drops of the "Glycifer" brand (270 mg ferrous iron) or the intake of 11 ml iron drops of the "Medic" brand (264 mg ferric iron).

RESULTS

The patient characteristics (ferrous versus ferric iron drops) were similar in terms of gender, age, haemoglobin, ferritin and previous gastric bypass surgery. The fasting baseline plasma iron concentration was median 5 μmol/l in both groups (p = 0.4). The maximum plasma iron concen-tration increase from baseline after oral intake of the iron drops was median 2 μmol/l (range: 0-8 μmol/l) in the group given ferric iron drops and 48 μmol/l (range: 14-78 μmol/l) when ferrous iron drops were used (p < 0.001).

CONCLUSION

OIAT performed with ferrous or ferric iron drops showed very different results with a lack of plasma iron concentration increase after ingestion of ferric iron drops.

FUNDING

none.

TRIAL REGISTRATION

not relevant.

摘要

引言

在口服铁吸收试验(OIAT)中,口服铁剂后血浆铁浓度的升高是肠道铁吸收的一个指标。我们描述了使用两种不同配方的口服铁滴剂进行OIAT的结果。

方法

该研究纳入了2013年1月1日至2014年6月17日在丹麦奥尔堡大学医院法尔瑟内科进行OIAT的所有患者(n = 24),他们使用的是亚铁滴剂“Glycifer”,以及2014年6月18日至11月3日进行OIAT的患者(n = 17),他们使用的是高铁滴剂“Medic”。在摄入9毫升“Glycifer”品牌铁滴剂(270毫克亚铁)或11毫升“Medic”品牌铁滴剂(264毫克高铁)之前以及之后90、180和240分钟采集静脉血样。

结果

在性别、年龄、血红蛋白、铁蛋白以及既往胃旁路手术方面,患者特征(亚铁滴剂与高铁滴剂)相似。两组空腹基线血浆铁浓度中位数均为5微摩尔/升(p = 0.4)。口服铁滴剂后,血浆铁浓度从基线的最大增加值在使用高铁滴剂的组中中位数为2微摩尔/升(范围:0 - 8微摩尔/升),而使用亚铁滴剂时为48微摩尔/升(范围:14 - 78微摩尔/升)(p < 0.001)。

结论

使用亚铁或高铁滴剂进行的OIAT显示出非常不同的结果,摄入高铁滴剂后血浆铁浓度没有升高。

资金来源

无。

试验注册

不相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验